Travere Therapeutics (TVTX) Total Debt (2014 - 2025)

Travere Therapeutics' (TVTX) quarterly Total Debt came in at $68.8 million in Q2 2025, little changed on a QoQ basis from $68.8 million in Q1 2025.

Travere Therapeutics (TVTX) Total Debt (2014 - 2025) Analysis & Trends

Travere Therapeutics (TVTX) has 10 years of Total Debt data on file, last reported at $68.8 million in Q2 2025.

  • Quarterly Total Debt changed N/A year-over-year to $68.8 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $68.8 million (changed N/A YoY) and the FY2024 annual result came in at $68.7 million, changed N/A from the prior year.
  • Total Debt was little changed at $68.8 million in Q2 2025, from $68.8 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $68.8 million in Q2 2025 to a low of $6.9 million in Q1 2023.
  • A 5-year average of $29.6 million and a median of $7.4 million in 2021 frame the typical range for Total Debt.
  • Annual changes were most pronounced in 2021 — Total Debt slumped 57.47% — and 2022, when it dropped 5.41%.
  • Tracing TVTX's Total Debt over 5 years: stood at $7.4 million in 2021, then retreated by 5.41% to $7.0 million in 2022, then retreated by 1.43% to $6.9 million in 2023, then surged by 895.33% to $68.7 million in 2024, then rose by 0.23% to $68.8 million in 2025.
  • The last three Total Debt figures came in at $68.8 million (Q2 2025), $68.8 million (Q1 2025), and $68.7 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.07 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 9.34 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 546.77 Mn
10 Travere Therapeutics 5.85 Bn 5.85 Bn 162.52 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 68.84 Mn
Mar 31, 2025 68.76 Mn
Dec 31, 2024 68.68 Mn
Sep 30, 2024 68.60 Mn
Jun 30, 2023 6.90 Mn
Mar 31, 2023 6.90 Mn
Dec 31, 2022 7.00 Mn
Sep 30, 2022 7.30 Mn
Jun 30, 2022 7.30 Mn
Mar 31, 2022 7.50 Mn
Dec 31, 2021 7.40 Mn
Dec 31, 2020 17.40 Mn
Mar 31, 2019 22.54 Mn
Dec 31, 2018 22.46 Mn
Sep 30, 2018 22.38 Mn
Jun 30, 2018 45.40 Mn
Mar 31, 2015 40.80 Mn
Sep 30, 2014 40.16 Mn